FORM 4
[ ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).         
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
                                                                                  
OMB APPROVAL
OMB Number: 3235-0287
Expires: January 31, 2008
Estimated average burden
hours per response... 0.5
                      
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934, Section 17(a) of the Public
Utility Holding Company Act of 1935 or Section 30(f) of the Investment Company Act of 1940
                      

1. Name and Address of Reporting Person *

CONWAY PHILIP J 		2. Issuer Name and Ticker or Trading Symbol

ROCHESTER MEDICAL CORPORATION [ ROCM ] 		5. Relationship of Reporting Person(s) to Issuer (Check all applicable)

_____ Director                      _____ 10% Owner
__ X __ Officer (give title below)      _____ Other (specify below)
Vice President
(Last)          (First)          (Middle)

420 PROSPECT STREET 		3. Date of Earliest Transaction (MM/DD/YYYY)

2/6/2008
(Street)

CHATFIELD, MN 55923
(City)        (State)        (Zip)
4. If Amendment, Date Original Filed (MM/DD/YYYY)

 
6. Individual or Joint/Group Filing (Check Applicable Line)

_ X _ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1.Title of Security
(Instr. 3) 		2. Trans. Date 2A. Deemed Execution Date, if any 3. Trans. Code
(Instr. 8) 		4. Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5) 		5. Amount of Securities Beneficially Owned Following Reported Transaction(s)
(Instr. 3 and 4) 		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock                  9600   I   By Spouse IRA  
Common Stock                  394143   D    

Table II - Derivative Securities Beneficially Owned ( e.g. , puts, calls, warrants, options, convertible securities)
1. Title of Derivate Security
(Instr. 3) 		2. Conversion or Exercise Price of Derivative Security 3. Trans. Date 3A. Deemed Execution Date, if any 4. Trans. Code
(Instr. 8) 		5. Number of Derivative Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5) 		6. Date Exercisable and Expiration Date 7. Title and Amount of Securities Underlying Derivative Security
(Instr. 3 and 4) 		8. Price of Derivative Security
(Instr. 5) 		9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Stock Option (Right to Buy)   $6.8125                     (1) 12/17/2008   Common Stock   10880     10880   D    
Stock Option (Right to Buy)   $6.8125                     (1) 12/17/2008   Common Stock   5120     5120   D    
Stock Option (Right to Buy)   $3.6563                     (1) 9/30/2009   Common Stock   10000     10000   D    
Stock Option (Right to Buy)   $3.6563                     (1) 9/30/2009   Common Stock   10000     10000   D    
Stock Option (Right to Buy)   $2.625                     (1) 2/20/2011   Common Stock   24000     24000   D    
Stock Option (Right to Buy)   $2.344                     (1) 4/6/2011   Common Stock   4882     4882   D    
Stock Option (Right to Buy)   $2.344                     (1) 4/6/2011   Common Stock   15118     15118   D    
Stock Option (Right to Buy)   $2.165                     (1) 10/16/2011   Common Stock   4998     4998   D    
Stock Option (Right to Buy)   $2.165                     (1) 10/16/2011   Common Stock   15002     15002   D    
Stock Option (Right to Buy)   $4.125                   1/2/2004   (2) 1/2/2013   Common Stock   10000     10000   D    
Stock Option (Right to Buy)   $4.625                   1/2/2005   (2) 1/2/2014   Common Stock   12000     12000   D    
Stock Option (Right to Buy)   $4.70                   1/1/2006   (2) 1/1/2015   Common Stock   30000     30000   D    
Stock Option (Right to Buy)   $5.70                   1/26/2007   (2) 1/26/2016   Common Stock   20000     20000   D    
Stock Option (Right to Buy)   $12.30                   11/21/2007   (2) 11/21/2016   Common Stock   20000     20000   D    
Stock Option (Right to Buy)   $11.23   2/6/2008     A     20000       2/6/2009   (2) 2/6/2018   Common Stock   20000   $0.00   20000   D    

Explanation of Responses:
( 1)  Currently 100% vested.
( 2)  Vest as to 25% annual cumulative installments beginning one year from date of grant, beginning this date.

Reporting Owners
Reporting Owner Name / Address
Relationships
Director 10% Owner Officer Other
CONWAY PHILIP J
420 PROSPECT STREET
CHATFIELD, MN 55923

Vice President

Signatures
David A. Jonas as power-of-attorney for Philip J. Conway 2/8/2008
** Signature of Reporting Person Date


Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4(b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number.
Rochester Medical Corp. (MM) (NASDAQ:ROCM)
Historical Stock Chart
From May 2024 to Jun 2024 Click Here for more Rochester Medical Corp. (MM) Charts.
Rochester Medical Corp. (MM) (NASDAQ:ROCM)
Historical Stock Chart
From Jun 2023 to Jun 2024 Click Here for more Rochester Medical Corp. (MM) Charts.